![Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532](https://ala.associates/wp-content/uploads/2021/05/Vincent-Charlon-1080x675.jpg)
![Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532](https://ala.associates/wp-content/uploads/2021/05/Vincent-Charlon-1080x675.jpg)
![NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering](https://ala.associates/wp-content/uploads/2021/05/20210510_160433-002-1080x675.jpeg)
NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering
![AELIX Therapeutics appoints Dr Melanie Rolli as CEO](https://ala.associates/wp-content/uploads/2021/05/Dr.-Rolli-1080x675.png)
AELIX Therapeutics appoints Dr Melanie Rolli as CEO
![MATWIN highlights four innovative projects in the fight against cancer](https://ala.associates/wp-content/uploads/2021/05/1-LOGO_QUADRI-1080x499.jpg)
MATWIN highlights four innovative projects in the fight against cancer
![Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target](https://ala.associates/wp-content/uploads/2021/05/Stephane-Degove-GamaMabs-Pharma-1-1080x675.jpg)
Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
![Robocath successfully completes first robotic coronary angioplasties in Belgium](https://ala.associates/wp-content/uploads/2021/05/Pr-S-Verheye-1080x675.jpg)
Robocath successfully completes first robotic coronary angioplasties in Belgium
![NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors](https://ala.associates/wp-content/uploads/2021/04/Jerome-Guillemont-1080x675.jpeg)
NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
![Minagro’s co-formulant in-can preservative, Sovinol P740/O, gains Ecocert certification](https://ala.associates/wp-content/uploads/2021/04/shutterstock_1176199399-1080x675.jpg)
Minagro’s co-formulant in-can preservative, Sovinol P740/O, gains Ecocert certification
![Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology](https://ala.associates/wp-content/uploads/2021/04/Ulkox-Oleoabrax-1080x675.png)
Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
![Tollys appoints Amina Zinaï, MD, as head of clinical development](https://ala.associates/wp-content/uploads/2021/04/Tollys.png)